| 2025/10/28 |  |
Overseas Regulatory Announcement
|
| 2025/10/28 | |
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED BOARD DIVERSITY POLICY
|
| 2025/10/28 | |
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED RULES OF PROCEDURES FOR THE NOMINATION AND REMUNERATION COMMITTEE OF THE BOARD OF DIRECTORS
|
| 2025/10/28 | |
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED RULES OF PROCEDURES FOR THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
|
| 2025/10/28 | |
2025 THIRD QUARTERLY REPORT
|
| 2025/10/23 | |
SUPPLEMENTARY ANNOUNCEMENT - DISCLOSABLE TRANSACTION: ACQUISITION OF 11.04% EQUITY INTEREST IN THE TARGET COMPANY
|
| 2025/10/17 | |
Overseas Regulatory Announcement
|
| 2025/10/14 | |
DATE OF BOARD MEETING
|
| 2025/09/28 | |
Overseas Regulatory Announcement
|
| 2025/09/28 | |
DISCLOSEABLE TRANSACTION: ACQUISITION OF 11.04% EQUITY INTEREST IN THE TARGET COMPANY
|
